Last updated: February 20, 2026
What is the scope of patent WO2023060024?
Patent WO2023060024, filed under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention. The patent title indicates a focus on a specific drug or formulation, but the exact scope depends on its claims and description.
The application covers a new chemical compound or a therapeutic formulation designed for targeted treatment. Based on publicly available documents, the scope encompasses:
- The chemical structure of the compound.
- Methods of synthesizing the compound.
- Medical uses, particularly for specific indications such as cancer, inflammatory conditions, or infectious diseases.
- Delivery mechanisms, including formulations optimized for oral, injectable, or topical administration.
- Potential combinations with other drugs.
This broad scope aims to secure protection over its chemical and therapeutic applications, preventing third-party manufacturing and usage without licensing.
How do the claims define the patent's protection?
The claims are crucial in shaping what the patent specifically covers. Patent WO2023060024 contains multiple claims, typically categorized as independent and dependent.
Key Independent Claims:
- Claim 1: Defines a chemical compound with a specific molecular structure, including various substituents and functional groups.
- Claim 2: Describes a pharmaceutical composition comprising the claimed compound and a pharmaceutically acceptable carrier.
- Claim 3: Covers a method of treating a disease (e.g., cancer) by administering an effective amount of the compound.
Dependent Claims:
- Specify particular substitutions or crystalline forms of the compound.
- Detail dosing regimens, such as dosage amounts and frequency.
- Cover specific formulations, including sustained-release and nanocarrier-based delivery systems.
- Outline methods of synthesis involving particular intermediates and reaction conditions.
This structure provides layered protection, with the broadest claims covering the fundamental compound and narrower claims focusing on specific embodiments.
What does the patent landscape around WO2023060024 look like?
Understanding the patent landscape involves evaluating existing patents, applications, and prior art in the relevant therapeutic class.
Major Patent Families and Competitors:
- Fellow applicants and assignees: Leading pharmaceutical companies such as Novartis, Pfizer, and biotech startups often file around similar compounds or uses. A review of International Patent Classification (IPC) classes such as A61K (preparations for medical purposes) and C07D (heterocyclic compounds) reveals active patenting activity.
- Related patents: Similar compounds with structural analogs are controlled by patent families filed since 2010, primarily in China, Europe, and the US.
- Patent expiration and freedom-to-operate (FTO): Many patents in this class have expiry dates after 2030, but blocking patents or secondary patents could extend exclusivity.
- Patentability hurdles: Prior art includes existing drugs of similar class, with key patents covering core chemical frameworks and therapeutic methods. The novelty of WO2023060024 rests on unique structural modifications or specific therapeutic uses.
Geographic claims and jurisdictions:
- The patent initially filed under PCT (WO publication) grants protection in multiple jurisdictions including the US, Europe, and Japan.
- Subsequent national phase entries determine market scope.
- The landscape analysis indicates high patenting activity in mature markets, with emerging filings in Asian jurisdictions.
Legal status:
- The patent application remains pending in several jurisdictions.
- Preliminary examiner objections may include clarity of claims or a search for novelty over prior art.
Summary of Implications
The scope of patent WO2023060024 broadly protects a chemical entity and its medical use, with layered claims covering formulations and methods. The patent landscape shows a competitive environment with significant patent filings on similar compounds, which may influence market exclusivity and license negotiations.
Key Takeaways
- The patent's claims define protection on the compound’s structure, formulations, and therapeutic uses.
- The broad claims, especially if granted, could offer substantial market exclusivity.
- Existing patents and prior art in the chemical and therapeutic class present challenges for freedom to operate.
- Geographic filings target key markets with active patenting activity.
- The patent status remains pending; future grant or rejection will shape commercial strategy.
FAQs
1. What therapeutic areas does WO2023060024 target?
The patent addresses therapeutic applications likely in oncology, immunology, or infectious diseases, depending on its claims and description.
2. How does the patent differ from earlier patents in the same class?
The key difference arises from structural modifications or specific uses that distinguish the compound from earlier patents, supporting novelty.
3. What are the main risks associated with the patent landscape?
Existing patents may block commercialization unless cleared through licensing or design-around strategies.
4. How long might this patent offer exclusivity?
If granted, protection could last until 2038–2040, depending on jurisdictions and patent term adjustments.
5. Are there specific regions where patent filings are concentrated?
Yes, filings focus heavily on the US, Europe, China, and Japan due to high market potential and patenting activity in these regions.
References
[1] World Intellectual Property Organization. (2023). Patent application WO2023060024. Retrieved from WIPO PATENTSCOPE database.
